UNR/CDSE1 expression as prognosis biomarker in resectable pancreatic ductal adenocarcinoma patients: A proof-of-concept

Pancreatic ductal adenocarcinoma is an aggressive form of pancreatic cancer and the fourth leading cause of cancer-related death. When possible, curative approaches are based on surgical resection, though not every patient is a candidate for surgery. There are clinical guidelines for the management...

Descripción completa

Detalles Bibliográficos
Autores principales: Martinez-Useros, Javier, Georgiev-Hristov, Tihomir, Fernández-Aceñero, María Jesús, Borrero-Palacios, Aurea, Indacochea, Alberto, Guerrero, Santiago, Li, Weiyao, Cebrián, Arancha, Gómez del Pulgar, Teresa, Puime-Otin, Alberto, del Puerto-Nevado, Laura, Rodríguez-Remírez, María, Pérez, Nuria, Celdrán, Angel, Gebauer, Fátima, Garcia-Foncillas, Jesus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5538752/
https://www.ncbi.nlm.nih.gov/pubmed/28763470
http://dx.doi.org/10.1371/journal.pone.0182044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5538752/
https://www.ncbi.nlm.nih.gov/pubmed/28763470
http://dx.doi.org/10.1371/journal.pone.0182044

Ejemplares similares